Accentia Files Plan Aimed At Boosting MS Drug

Law360, New York (June 1, 2010, 3:59 PM EDT) -- Accentia Biopharmaceuticals Inc. has filed a proposed reorganization plan designed to support a key drug development program, moving the company one step closer to emerging from bankruptcy protection as early as this summer.

The reorganization plan, filed Friday with the U.S. Bankruptcy Court for the Middle District of Florida, will strengthen the company's financial position and balance sheet while restructuring the terms of its debts to allow it to service its long-term obligations, Accentia said Tuesday.

The Tampa, Fla.-based company, a portfolio company of Hopkins Capital...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.